The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
"(VelosBio) said it had treated 16 haematological cancer subjects with its anti-Ror1 antibody-drug conjugate VLS-101, and a very early case report yielded an unconfirmed partial remission in a heavily pretreated subject."
Am i reading this right???? 1 unconfirmed partial remission out of 16 patients... is worth $2.75 Billion...
fancy giving a synopsis of their experience of Redmile? From what I read it seems the majority accepted the 15p offer which was a 240% premium to SP at the time. But since that 2 major deals announced in fairly short order. Any thoughts on why their BOD recommended the offer if those deals were in the pipeline??? And if they weren't then what involvement did Red mile have in them?
Douve... The point i'm making is that it isn't/wasn't one or the other... if we'd got 2 mill upfront from a TAG deal that's a drop in the ocean compared to what we've just raised. In all likelihood we would have still raised this cash regardless of whether the deal was done or not.
I agree we have missed many many many deadlines over the years and I am as frustrated as anyone about this, but if you'd told me a year ago we'd be in this position I'd never have believed you.
Knowlesi - this is good news! Imagine if I told the Knowlesi of 2019 that Scancell would be at 17.5p and have £45 Million in the bank, you would have laughed me out of town. For me the only threat is a low ball take over offer, but even that would see all of us well into the black. Let's all take a minute to reflect on how far we've come.
I think thinking of today's fund raise as a reaction to the deal not going well is a red herring. The deal would only have brought in single digit millions upfront, not the 33 million this raise has. So I don't think they are really connected at all. I am though reminded of one of CH's answers in the Proactive interview... when asked if we were a take over target for the likes of Biontech, he said something along the lines of becoming a Biontech ourselves... now with today's news and the comments around a Nasdaq listing... it seems he may have been actually giving a bigger clue than we all realised at the time!